Evidence map›Paper›PMID 36498991›Full record

ArticleInternational journal of molecular sciences2022

The Role of Interferon Regulatory Factor 1 in Regulating Microglial Activation and Retinal Inflammation.

Xu Yang, Valeria Diaz, Hu Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Immune system expression profiling in patients experiencing low back pain: A pilot study.PM & R : the journal of injury, function, and rehabilitation · 2026
    Observational
  2. Article
  3. Microglial polarization in retinal neovascularization: Friend or foe?Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  4. Article
  5. The Immunopathogenesis of uveitis.Frontiers in medicine · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Xu YangDepartment of Ophthalmology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.
Valeria DiazDepartment of Ophthalmology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.ORCID 0000-0002-8355-5022
Hu HuangDepartment of Ophthalmology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.ORCID 0000-0003-2843-0320
University of Missouri · USHe Eye Hospital · CN

Funding

Regulation of blood-retinal barrier by placental growth factor.R01EY027824 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Hu Huang · 2017 to 2026
$4.2M
MU Start-up fund NANEI NIH HHS R01 EY027824NIH fund EY027824
6 · The paper itself

Abstract

Microglia are resident immune cells in the central nervous system (CNS). Microglial activation plays a prominent role in neuroinflammation and CNS diseases. However, the underlying mechanisms of microglial activation are not well understood. Here, we report that the transcription factor interferon regulatory factor 1 (IRF1) plays critical roles in microglial activation and retinal inflammation by regulating pro- and anti-inflammatory gene expression. IRF1 expression was upregulated in activated retinal microglia compared to those at the steady state. IRF1 knockout (KO) in BV2 microglia cells (BV2

Indexed as

InflammationInterferon Regulatory Factor-1MicrogliaAnimalsHumansLipopolysaccharidesMiceRatsRetinaInterferon Regulatory Factor-1LipopolysaccharidesCRISPR-Cas9IRF1microgliaretina inflammationtranscription factor

Identifiers

PMID36498991
PMCPMC9739975
OpenAlexW4309852290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.